Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2Db class i molecule

FASEB Journal

Volumn 31, Issue 6, 2017, Pages 2267-2275

  Kelcher, April M Huseby ^a   Atanga, Pascal A ^b   Gamez, Jeffrey D ^b   Garcia, Luz M Cumba ^a   Teclaw, Stephanie J ^a   Pavelko, Kevin D ^a   Macura, Slobodan I ^b   Johnson, Aaron J ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

CD8 T cells; MHC class I; Neurodegeneration; TMEV; Viral clearance

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BRAIN ATROPHY; BRAIN NERVE CELL; CD8+ T LYMPHOCYTE; CLINICAL EVALUATION; FLOW CYTOMETRY; HIPPOCAMPUS; HISTOLOGY; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PICORNAVIRUS INFECTION; PRIORITY JOURNAL; THEILER'S MURINE ENCEPHALOMYELITIS VIRUS; TRANSGENIC MOUSE; VIRAL CLEARANCE; VIRUS LOAD; ANIMAL; ATROPHY; BRAIN; BRAIN DISEASE; DISEASE MODEL; GENE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INBRED MOUSE STRAIN; NERVE CELL; PATHOLOGY; PHYSIOLOGY; THEILOVIRUS; VIROLOGY;

ANIMALS; ATROPHY; BRAIN; BRAIN DISEASES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NEURONS; PICORNAVIRIDAE INFECTIONS; THEILOVIRUS; VIRAL LOAD;

EID: 85020313002     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201601055R     Document Type: Article

References (47)

1. Johnson, A. J., Suidan, G. L., McDole, J., and Pirko, I. (2007) TheCD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology? Int. Rev. Neurobiol. 79, 73-97
2. Petito, C.K., Torres-Muñoz, J.E., Zielger, F., andMcCarthy, M. (2006) Brain CD8+ and cytotoxic T lymphocytes are associated with, andmay be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. J. Neurovirol. 12, 272-283
3. Likeman, M., Anderson, V. M., Stevens, J. M., Waldman, A. D., Godbolt, A. K., Frost, C., Rossor, M. N., and Fox, N. C. (2005) Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch. Neurol. 62, 1410-1415
4. Farid, N., Girard, H. M., Kemmotsu, N., Smith, M. E., Magda, S. W., Lim, W. Y., Lee, R. R., and McDonald, C. R. (2012) Temporal lobe epilepsy: quantitative MR volumetry in detection of hippocampal atrophy. Radiology 264, 542-550
5. Zamolodchikov, D., and Strickland, S. (2016) A possible new role for Ab in vascular and inflammatory dysfunction in Alzheimer's disease. Thromb. Res. 141, S59-S61
6. Mandolesi, G., Gentile, A., Musella, A., Fresegna, D., De Vito, F., Bullitta, S., Sepman, H., Marfia, G. A., and Centonze, D. (2015) Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis. Nat. Rev. Neurol. 11, 711-724
7. Vezzani, A., Aronica, E., Mazarati, A., and Pittman, Q. J. (2013) Epilepsy and brain inflammation. Exp. Neurol. 244, 11-21
8. Hainke, U., Thomas, K., and Ziemssen, T. (2016) Laquinimod in the treatment of relapsing remitting multiple sclerosis. Expert Opin. Drug Metab. Toxicol. 12, 701-709
9. Constantinescu, S. E., and Constantinescu, C. S. (2016) Laquinimod (ABR-215062) for the treatment of relapsingmultiple sclerosis. Expert Rev. Clin. Pharmacol. 9, 49-57
10. Kappos, L., Radue, E. W., O'Connor, P., Polman, C., Hohlfeld, R., Calabresi, P., Selmaj, K., Agoropoulou, C., Leyk, M., Zhang-Auberson, L., and Burtin, P.; FREEDOMS Study Group. (2010) A placebocontrolled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387-401
11. Chataway, J., Schuerer, N., Alsanousi, A., Chan, D., MacManus, D., Hunter, K., Anderson, V., Bangham, C. R., Clegg, S., Nielsen, C., Fox, N.C., Wilkie, D., Nicholas, J.M., Calder, V.L., Greenwood, J., Frost, C., and Nicholas, R. (2014) Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 383, 2213-2221
12. McGavern, D.B., Murray, P. D., Rivera-Quiñones, C., Schmelzer, J. D., Low, P.A., andRodriguez, M. (2000)Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelinationin a chronic inflammatorymodel ofmultiple sclerosis. Brain 123, 519-531
13. McGavern, D. B., Murray, P. D., and Rodriguez, M. (1999) Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss inamodel of progressive neurologic injury. J.Neurosci. Res. 58, 492-504
14. Denic, A., Johnson, A. J., Bieber, A. J., Warrington, A. E., Rodriguez, M., and Pirko, I. (2011) The relevance of animal models in multiple sclerosis research. Pathophysiology 18, 21-29
15. Pirko, I., Johnson, A. J., Chen, Y., Lindquist, D.M., Lohrey, A. K., Ying, J., and Dunn, R. S. (2011) Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 54, 802-806
16. McDole, J., Johnson, A. J., and Pirko, I. (2006)The role ofCD8+ T-cells in lesion formation and axonal dysfunction in multiple sclerosis. Neurol. Res. 28, 256-261
17. Rodriguez, M., and David, C. S. (1985) Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 135, 2145-2148
18. Brahic, M., Bureau, J. F., and Michiels, T. (2005) The genetics of the persistent infection and demyelinating disease caused by Theiler's virus. Annu. Rev. Microbiol. 59, 279-298
19. Altintas, A., Cai, Z., Pease, L.R., andRodriguez, M. (1993)Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J. Immunol. 151, 2803-2812
20. Azoulay-Cayla, A., Syan, S., Brahic, M., and Bureau, J. F. (2001) Roles of the H-2Db and H-Kb genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J. Gen. Virol. 82, 1043-1047
21. Lin, X., Njenga, M. K., Johnson, A. J., Pavelko, K. D., David, C. S., Pease, L. R., and Rodriguez, M. (2002) Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2b mice inhibits resistance to virus-induced demyelination. J. Virol. 76, 7799-7811
22. Mendez-Fernandez, Y. V., Johnson, A. J., Rodriguez, M., and Pease, L. R. (2003) Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur. J. Immunol. 33, 2501-2510
23. Pavelko, K. D., Mendez-Fernandez, Y., Bell, M. P., Hansen, M. J., Johnson, A. J., David, C. S., Rodriguez, M., and Pease, L. R. (2012) Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity. PLoS Pathog. 8, e1002541
24. Johnson, A. J., Njenga, M. K., Hansen, M. J., Kuhns, S. T., Chen, L., Rodriguez, M., and Pease, L. R. (1999) Prevalent class I-restricted Tcell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J. Virol. 73, 3702-3708
25. Azoulay, A., Brahic, M., and Bureau, J. F. (1994) FVBmice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. J. Virol. 68, 4049-4052
26. Tsunoda, I., and Fujinami, R. S. (2010) Neuropathogenesis of Theiler'smurine encephalomyelitis virus infection, an animalmodel for multiple sclerosis. J. Neuroimmune Pharmacol. 5, 355-369
27. Pavelko, K. D., Girtman, M. A., Mitsunaga, Y., Mendez-Fernandez, Y. V., Bell, M. P., Hansen, M. J., Allen, K. S., Rodriguez, M., and Pease, L. R. (2011) Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy. PLoS One 6, e20217
28. Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101-1108
29. Robb, R. A., and Barillot, C. (1989) Interactive display and analysis of 3-D medical images. IEEE Trans. Med. Imaging 8, 217-226
30. Johnson, H. L., Chen, Y., Jin, F., Hanson, L.M., Gamez, J. D., Pirko, I., and Johnson, A. J. (2012) CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support. J. Immunol. 189, 1937-1945
31. McDole, J.R., Danzer, S.C., Pun, R. Y., Chen, Y., Johnson, H. L., Pirko, I., and Johnson, A. J. (2010) Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNSinfiltrating CD8 T cells. Am. J. Pathol. 177, 1823-1833
32. Altman, J. D., Moss, P. A., Goulder, P. J., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M. M. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96
33. Reed, B.K., Chopp, L. B., Malo, C. S., Renner, D. N., Van Keulen, V. S., Girtman, M. A., Nevala, W. N., Pavelko, K. D., Gil, D., Schrum, A. G., Johnson, A. J., and Pease, L. R. (2015)A versatile simple capture assay for assessing the structural integrity ofMHCmultimer reagents. PLoS One 10, e0137984
34. Pirko, I., Suidan, G.L., Rodriguez, M., andJohnson, A. J. (2008)Acute hemorrhagic demyelination in a murinemodel of multiple sclerosis. J. Neuroinflammation 5, 31
35. Pavelko, K. D., Pease, L. R., David, C. S., and Rodriguez, M. (2007) Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination. Brain Pathol. 17, 184-196
36. Cumba Garcia, L. M., Huseby Kelcher, A. M., Malo, C. S., and Johnson, A. J. (2016) Superior isolation of antigen-specific brain infiltratingTcells usingmanual homogenization technique. J. Immunol. Methods 439, 23-28
37. Johnson, A. J., Upshaw, J., Pavelko, K.D., Rodriguez, M., andPease, L. R. (2001) Preservation of motor function by inhibition of CD8+ virus peptide-specificTcells inTheiler's virus infection.FASEBJ.15, 2760-2762
38. Mendez-Fernandez, Y. V., Hansen, M. J., Rodriguez, M., and Pease, L. R. (2005) Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection. J. Virol. 79, 3063-3070
39. Stadelmann, C. (2011) Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr. Opin. Neurol. 24, 224-229
40. Dell'Orco, J. M., Wasserman, A. H., Chopra, R., Ingram, M. A., Hu, Y. S., Singh, V., Wulff, H., Opal, P., Orr, H. T., and Shakkottai, V. G. (2015) Neuronal atrophy early in degenerative ataxia is a compensatory mechanism to regulate membrane excitability. J. Neurosci. 35, 11292-11307
41. Siffrin, V., Vogt, J., Radbruch, H., Nitsch, R., and Zipp, F. (2010) Multiple sclerosis - candidate mechanisms underlying CNS atrophy. Trends Neurosci. 33, 202-210
42. Miller, S. D., and Eagar, T. N. (2001) Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virusinduced demyelinating diseases. Adv. Exp. Med. Biol. 490, 99-107
43. Elmer, B. M., and McAllister, A. K. (2012) Major histocompatibility complex class I proteins in brain development and plasticity. Trends Neurosci. 35, 660-670
44. Lee, H., Brott, B. K., Kirkby, L. A., Adelson, J. D., Cheng, S., Feller, M. B., Datwani, A., and Shatz, C. J. (2014) Synapse elimination and learning rules co-regulated by MHC class I H2-Db. Nature 509, 195-200
45. Penn, A. A., Riquelme, P. A., Feller, M. B., and Shatz, C. J. (1998) Competition in retinogeniculate patterning driven by spontaneous activity. Science 279, 2108-2112
46. Boulanger, L.M. (2009) Immune proteins in brain development and synaptic plasticity. Neuron 64, 93-109
47. Shatz, C. J. (2009) MHC class I: an unexpected role in neuronal plasticity. Neuron 64, 40-45